TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5856$ +1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Humacyte Inc (HUMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 138 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HUMA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
149 128 161 138 115 138 163 139 92 116 111 138
103 83 118 96 23 48 74 52 41 68 64 93
100 80 116 94 21 45 63 38 19 50 49 80
100 80 116 94 21 45 63 38 19 50 49 80
0.0 0.0 0.0 0.5 0.4 1.1 0.4 0.4 0.3
0.0 8.0 11 18 14 9.9 7.0
112 115 135 167 178 191 127 135 96 113 99 107
15 18 14 18 21 20 20 21 26 18 16 15
2.5 2.6 2.7 2.8 2.9 2.9 3.0 5.2 2.7 2.4 2.4 1.5
3.0 6.5 3.5 6.0 6.9 4.5 5.6 6.6 9.6 5.4 5.1 4.2
37 39 35 36 36
37 14 26 -28 -64 -53 36 4.1 -4.8 3.1 12 31
-512 -537 -569 -626 -665 -686 -647 -685 -702 -727 -744 -781
103 104 108 119 119 118 132 155 158 158 198 234

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?